Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Vasogen receives approval in Canada to proceed with psoriasis trial

March 9, 2001

Phase I/II pharmacokinetic and safety data reported at AAD for Atrisone

March 8, 2001

Phase Ib trial of RK-0202 for oral mucositis to commence shortly

March 8, 2001

Cellegy seeks marketing approval for Rectogesic in South Korea

March 8, 2001

Favorable data presented this week for subcutaneous anti-CD11a antibody product for psoriasis

March 7, 2001

Switch Biotech and TUM enter research alliance on atopic dermatitis

March 7, 2001

Biogen's disease-modifying psoriasis therapy maintains efficacy upon retreatment

March 7, 2001

Positive phase III results announced for Metvix PDTas treatment of actinic keratosis

March 7, 2001

Phase IIa trial results presented at AAD meeting for ABX-IL-8 in psoriasis

March 6, 2001

AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial

March 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...